3,4-dihydroxyphenylglycol has been researched along with Acute Confusional Senile Dementia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Guimarães, J; Henriques, T; Portela Moreira, I; Vieira-Coelho, MA | 1 |
Berretta, N; Cavallucci, V; D'Amelio, M; Mercuri, NB; Nisticò, R; Nobili, A | 1 |
Ehrlich, ME; Fraser, PE; Gandy, S; Kim, SH; St George-Hyslop, PH; Westaway, D | 1 |
Goldstein, DS; Holmes, C; Kopin, IJ; Patronas, N | 1 |
Ahlskog, JE; Kokmen, E; O'Brien, JF; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
Goldstein, DS; Holmes, C; Peskind, ER; Raskind, MA | 1 |
Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T | 1 |
1 review(s) available for 3,4-dihydroxyphenylglycol and Acute Confusional Senile Dementia
Article | Year |
---|---|
Dysfunction of norepinephrine and its metabolites in Alzheimer's dementia - A review with meta-analysis.
Topics: Alzheimer Disease; Humans; Methoxyhydroxyphenylglycol; Norepinephrine | 2023 |
6 other study(ies) available for 3,4-dihydroxyphenylglycol and Acute Confusional Senile Dementia
Article | Year |
---|---|
Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Calcineurin Inhibitors; Caspase 3; Dendrites; Disease Models, Animal; Disks Large Homolog 4 Protein; Drug Evaluation, Preclinical; Excitatory Postsynaptic Potentials; Guanylate Kinases; Long-Term Synaptic Depression; Male; Membrane Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Neuroprotective Agents; Phosphorylation; Phosphoserine; Post-Synaptic Density; Protein Processing, Post-Translational; Receptors, AMPA; Receptors, Metabotropic Glutamate; Tacrolimus | 2013 |
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.
Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Humans; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Nerve Endings; Peptide Fragments; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2010 |
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.
Topics: Aged; Alzheimer Disease; Autonomic Nervous System Diseases; Case-Control Studies; Catechols; Chronic Disease; Humans; Hypotension, Orthostatic; Linear Models; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Norepinephrine | 2003 |
Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Blood Platelets; Catecholamines; Epinephrine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Norepinephrine; Parkinson Disease | 1996 |
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine | 1999 |
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine | 1986 |